Clinical Trials at AAPRI Clinical Research Institute
Our focus is allergies and asthma, but we are also actively pursuing clinical research studies in other areas of healthcare. Our research department is always adding new clinical trials, and we work with each patient to find the study that is appropriate and comfortable for you.
If you are accepted for a clinical trial, you will receive all study-related procedures and medications at no cost. You may also be compensated for your time and travel!
Below, you will find the general requirements for each trial. If you are interested, please let us know by clicking the button below the study description or calling us at 401-681-4960 Ext 115. A member of our research team will contact you to discuss your eligibility.
Current and Upcoming Clinical Trials
Chronic Cough Study for Women with Cough & Stress Urinary Incontinence
Sponsor: Merck
Location: Warwick office
We’re seeking participants who suffer from chronic cough. Potential participants must have a physician diagnosis of chronic cough with a documented history of ≥12 months.
You may be able to take part in this research study if you:
- Are a female, aged 18 or older
- Have had a chronic cough (defined as greater than 8 weeks after onset of symptoms, for ≥12 months)
- Have had symptoms of stress urinary incontinence, defined as involuntary loss of urine on effort, physical exertion or on sneezing or coughing for 3 months or longer
- Have been a non-smoker for at least 12 months
- BMI ≤40
Approximate time in study: 22 Weeks, 6 in-office visits
Contact AAPRI about this study
Atopic Dermatitis
Sponsor: AoBiome
Location: Warwick office
- Male and Female 18 years to 65 years
- With Mild to Moderate Atopic Dermatitis or Eczema (condition that makes your skin red and itchy) which causes a need for you to scratch and can lead to information (redness of the skin)
- Have suffered with itchy, skin for over 12 months.
- This study drug is a topical spray that is being tested and is not a topical steroid.
This study is approximately 11 weeks long, there are 5 clinic visits and 2 telephone calls. You will be compensated for time and travel up to $375.00. There will be no charge to you or your insurance company for any of the visits related to participation in the trial.
Contact AAPRI about this study
Atopic Dermatitis
Sponsor: Eli Lily
Location: Warwick office
- Male and Females 18 years to 55 years of age
- Have a history of inadequate response to treatment with topical medications.
Depending on the preference of the study site or the study participant, some of the study visits may be performed either remotely or on site.
You will be in this study for up to approximately 32 weeks, and you will need to come to the study center at least 7 to 11 times over this period. You will be compensated up to $500.00 for completion of the trial for your time and travel. Compensation will occur after each competed visit. There will be no charge to you or your insurance company for any of the visits related to participation in the trial.
Contact AAPRI about this study
Asthma
Sponsor: GlaxoSmithKline (Also known as GSK)
Location: Warwick office
- Adults and adolescents ≥12 years of age.
- Documented diagnosis of Asthma for 2 years or greater.
- Using daily asthma medications to control symptoms
- Non-Smoker
- Receiving either Nucala or Fasenra for greater than 12 months and have a documented benefit with their medication.
The study will last approximately (15 months), with 17 visits (after the first 2 visits being 2 weeks apart the other visits will be every 4 weeks).
You will receive $83 for each completed study visit except Visit 2 where you will be paid $200. If you are able to complete the trial and complete all visits the compensation will be up to $ 1,445.00. You will be paid at the end of each visit for your time and travel.
Contact AAPRI about this study
Asthma
Sponsor: GlaxoSmithKline (Also known as GSK)
Location: Warwick office
- Age: Adults and adolescents ≥12 years of age.
- Documented diagnosis of Asthma for 2 years or greater.
- Using daily asthma medications to control symptoms for a minimum of 12 months.
- Non-Smoker
- Have had 2 Asthma “Attacks” in the previous 12 months requiring prednisone, or doubling of your daily asthma medication.
The study will last approximately (32 weeks), with 16 visits (after the first 2 visits being 2 weeks apart the other visits will be every 4 weeks).
You will receive $83 for each completed study visit except Visit 2 where you will be paid $200. If you are able to complete the trial and complete all visits the compensation will be up to $ 1,528.00. You will be paid at the end of each visit for your time and travel.
Contact AAPRI about this study
Please note: You must be willing to sign an Informed Consent form to participate in a clinical trial. This is not a complete list of study requirements. Once you contact us about participation, a member of our research team will contact you to discuss your eligibility.